Bee venom - Apimeds

Drug Profile

Bee venom - Apimeds

Alternative Names: Apitox; Apitoxin; honeybee toxin - Apimeds; purified bee venom - Apimeds

Latest Information Update: 28 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Apimeds
  • Class Analgesics; Anti-inflammatories; Venoms
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Osteoarthritis
  • Phase III Multiple sclerosis

Most Recent Events

  • 28 Jul 2016 Launched for Osteoarthritis in South Korea (Intradermal)
  • 01 Dec 2015 Phase-III clinical trials in Multiple sclerosis in USA (Intradermal)
  • 25 Apr 2010 Phase-III clinical trials in Osteoarthritis in USA (Intradermal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top